Home
All updates
EDGE Insights
Industries
Company Search
My Watchlists (Beta)

All Updates

Filter

Partnerships

INOVIQ and Promega sign global supply and distribution agreement for EXO-NET exosome isolation tool

Precision Medicine

Apr 15, 2024

This week:

Funding

Matr Foods raises EUR 20 million in debt funding to build mycelium meat factory

Plant-based Meat

Today

Last week:

M&A

Platform Science to acquire Trimble's global transportation telematics business units

Truck Industry Tech

Yesterday

Funding

Whatfix raises USD 100 million in Series E funding to expand business

EdTech: Corporate Learning

Yesterday

Product updates

Sky Mavis launches cross-game onboarding solution

Web3 Ecosystem

Sep 14, 2024

Funding

Bicara Therapeutics raises USD 315 million in IPO; plans to develop lead candidate ficerafusp alfa

Precision Medicine

Sep 13, 2024

Partnerships

Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment

Precision Medicine

Sep 13, 2024

Partnerships

Moffitt Cancer Center partners with AstraZeneca to advance oncology cell therapies

Cell & Gene Therapy

Sep 13, 2024

Product updates

Quandela launches European quantum computer in North America

Quantum Computing

Sep 13, 2024

Partnerships

IonQ achieves high qubit gate fidelity on barium development platform

Quantum Computing

Sep 13, 2024

Partnerships

Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment

Clinical Trial Technology

Sep 13, 2024

Precision Medicine

View industry hub

Apr 15, 2024

INOVIQ and Promega sign global supply and distribution agreement for EXO-NET exosome isolation tool

Partnerships

INOVIQ has partnered with Promega Corporation to generate commercial exosome isolation and nucleic acid extraction solutions.
The partnership aims to commercialize INOVIQ’s EXO-NET, a tool for capturing exosomes, with the help of Promega’s resources in nucleic acid purification. EXO-NET is an immunoaffinity magnetic bead-based isolation system designed for capturing exosomes from various human biofluids.
Promega Corporation is a biotechnology and life sciences research company. It offers various products, including tools and technologies that support scientific work in cell biology, DNA, RNA, and protein analysis, drug development, and molecular diagnostics fields. Promega’s proprietary technologies include the HaloTa Protein Labeling and Analysis, HiBiT Protein Tagging, and NanoLuc Luciferase, used in research and industrial applications.

Contact us

Gain access to all industry hubs, market maps, research tools, and more

Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.